Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
Q/C TECHNOLOGIES, INC. (QCLS)
Standardized SEC financial data for Q/C TECHNOLOGIES, INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001321834 · NASDAQ · In Vitro & In Vivo Diagnostic Substances.
Gross margin
30.4%
Operating margin
-624.4%
Net margin
-950.2%
Revenue growth (YoY)
-5.3%
Return on equity
-68.9%
Free cash flow
-$10.8M
Current ratio
3.00×
EPS (diluted)
$-8.66
Ratios for fiscal year 2019, standardized from SEC filings.